Trial intelligence / Profile preview

The D3 Study: Dexycu vs Prednisolone Acetate in Cataract Surgery

NCT04273282Phase 4Completed

Sponsor
Research Insight
Start
Dec 2019
Primary completion
Nov 2020
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of IBI-10090 in post-operative ocular inflammation, post-operative ocular pain, sponsored by Research Insight. Started Dec 2019; status: completed.

02

Drugs

IBI-10090
03

Conditions

post-operative ocular inflammationpost-operative ocular pain

Beyond the preview

Go deeper on NCT04273282.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04273282.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call